STOCK TITAN

ZOOZ (ZOOZ) files 6-K for flexible $10.95M equity offering

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

On 29 July 2025, ZOOZ Power Ltd. (NASDAQ: ZOOZ) filed a Form 6-K announcing an at-the-market (“ATM”) equity program. The company entered into a Sales Agreement with Chardan Capital Markets that allows ZOOZ to issue and sell up to $10.95 million of ordinary shares (par value NIS 0.00286) from time to time off its effective F-3 shelf (File No. 333-288280). Chardan will act as sales agent, executing transactions directly on the Nasdaq Capital Market or other trading venues permitted under Rule 415(a)(4).

Key terms: (i) Sales are discretionary; ZOOZ may set a minimum acceptable price and is not obligated to sell any shares, (ii) commission equals 3.0% of gross proceeds, and (iii) either party may terminate the agreement as provided therein. Legal opinions (Exhibit 5.1) and the full Sales Agreement (Exhibit 10.1) are incorporated by reference into the company’s S-8 and F-3 filings.

The ATM facility offers flexible, relatively low-cost access to capital but could dilute existing shareholders if fully utilized. No earnings or operational updates were provided in this filing.

Positive

  • Flexible capital access: ATM allows ZOOZ to raise up to $10.95 M quickly as funding needs arise.
  • Market-standard cost: 3% sales commission is in line with peer offerings, limiting issuance friction.

Negative

  • Dilution risk: Full utilization would increase share count and may pressure per-share metrics.
  • Capital need signal: Seeking equity funding can indicate limited internal cash generation or alternative financing options.

Insights

TL;DR: Neutral—small ATM gives liquidity flexibility but introduces modest dilution risk.

The $10.95 M program (size undisclosed relative to market cap) equips ZOOZ with optional, just-in-time funding for working capital or growth without the lead time and discount typical of marketed follow-ons. A 3% agent fee is market-standard. Because issuance is discretionary, impact hinges on execution price and eventual take-up; if shares are sold near market without large volume, dilution should be gradual. Absent guidance on use of proceeds, credit or growth catalysts, I classify the filing as informational and moderately supportive rather than value-changing.

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

Report of Foreign Private Issuer Pursuant to Rule 13a-16
or 15
d-16 Under the Securities Exchange Act of 1934

 

For the month of July 2025

 

Commission File Number: 001-42005

 

ZOOZ Power Ltd.

(Translation of registrant’s name into English)

 

4B Hamelacha St.

Lod 7152008

Israel

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒ Form 40-F ☐

 

 

 

 

 

 

On July 29, 2025, ZOOZ Power Ltd. (the “Company”) entered into a Sales Agreement (the “Sales Agreement”) with Chardan Capital Markets LLC (“Chardan”), as sales agent, pursuant to which the Company may offer and sell, from time to time through Chardan, ordinary shares, par value NIS 0.00286 per share, of the Company (the “Ordinary Shares”). The offer and sale of the Ordinary Shares, if any, will be made initially pursuant to the Company’s shelf registration statement on Form F-3 (File No. 333-288280), previously declared effective by the Securities and Exchange Commission on July 9, 2025 (the “Registration Statement”), as supplemented by the prospectus supplement relating to the Ordinary Shares which may be issued from time to time pursuant to the Sales Agreement, dated July 29, 2025 (the “Prospectus Supplement”). Pursuant to the Prospectus Supplement, the Company may offer and sell up to $10.95 million of Ordinary Shares (the “Shares”).

 

Under the Sales Agreement, Chardan may sell Shares by any method permitted by law and deemed to be an “at the market offering” as defined in Rule 415(a)(4) promulgated under the Securities Act of 1933, as amended, including sales made directly on The Nasdaq Capital Market or on any other existing trading market for the Ordinary Shares.

 

The Company may instruct Chardan not to sell Shares if the sales cannot be effected at or above the price designated by the Company from time to time. The Company is not obligated to make any sales of Shares under the Sales Agreement and no assurance can be given that it will sell any Shares under the Sales Agreement, or, if it does, as to the price or number of Shares that it will sell, or the dates on which any such sales will take place. The aggregate compensation payable to Chardan as sales agent is an amount equal to 3.0% of the aggregate gross sales price of the Shares sold pursuant to the Sales Agreement.

 

The Sales Agreement may be terminated by either party as set forth in the Sales Agreement.

 

The foregoing description of the Sales Agreement is not complete and is qualified in its entirety by reference to the full text of such agreement, a copy of which is furnished herewith as Exhibit 10.1 to this Report on Form 6-K and is incorporated herein by reference.

 

A copy of the opinion of Shibolet & Co., Law Firm, Israeli counsel to the Company, relating to the legality of the issuance and sale of the Shares pursuant to the Sales Agreement, is attached as Exhibit 5.1 hereto. This opinion is also furnished with reference to, and is hereby incorporated by reference into, the Registration Statement.

 

This Report on Form 6-K shall not constitute an offer to sell or the solicitation of an offer to buy the Shares, nor shall there be any offer, solicitation, or sale of the Shares in any state in which such offer, solicitation or sale would be unlawful.

 

This Report on Form 6-K, including the exhibits hereto, is hereby incorporated by reference into the Company’s Registration Statement on Form S-8, File No. 333-280741 and into the Company’s Registration Statements on Form F-3, File Nos. 333-288280 and 333-288916.

 

Exhibit Index

 

Exhibit
No.
  Description
5.1   Opinion of Shibolet & Co.
10.1   Sales Agreement, dated July 29, 2025, by and between ZOOZ Power Ltd. and Chardan Capital Markets LLC
23.1   Consent of Shibolet & Co. (contained in Exhibit 5.1)
104   Cover Page Interactive Data File (embedded within the inline XBRL document).

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  ZOOZ Power Ltd.
     
Dated: July 29, 2025 By: /s/ Avi Cohen
  Name: Avi Cohen
  Title: Executive Chairman of the Board

 

 

 

FAQ

How much can ZOOZ Power (ZOOZ) raise under the new ATM program?

The Sales Agreement permits issuance of up to $10.95 million in ordinary shares.

What fee will ZOOZ pay to Chardan for selling the shares?

Chardan will receive a 3.0% commission on the aggregate gross sales price of shares sold.

Is ZOOZ obligated to sell shares immediately?

No. The company may choose when, if at all, to sell and can set a minimum acceptable price.

Where will the ATM sales be executed?

Sales may occur on The Nasdaq Capital Market or any other existing trading market for ZOOZ’s ordinary shares.

Can the Sales Agreement be terminated?

Yes. Either ZOOZ or Chardan may terminate the agreement as described in the contract.
ZOOZ STRATEGY

NASDAQ:ZOOZ

View ZOOZ Stock Overview

ZOOZ Rankings

ZOOZ Latest News

ZOOZ Latest SEC Filings

ZOOZ Stock Data

61.04M
158.49M
Specialty Retail
Consumer Cyclical
Link
Israel
Lod